Data / Form D filings / Rib-X Pharmaceuticals, Inc.
Rib-X Pharmaceuticals, Inc.: Form D filings
Rib-X Pharmaceuticals, Inc., a pharmaceuticals company in New Haven, CT, filed 3 Form D notices with the SEC between 2010 and 2012. The latest, on November 30, 2012, reports $18.7 million sold of a $67.5 million offering to 4 investors.
Find out what Rib-X Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 300 GEORGE STREET, SUITE 301, New Haven, CT, 06511
- Phone
- (203) 624-5606
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1164994
The full lists. Form D filings in Connecticut: 428 rows, $21.40, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 30, 2012 | New notice | $67,500,000 | $18,686,500 | $48,813,500 | 4 | Nov 15, 2012 | sec.gov |
| Jan 28, 2011 | New notice | $22,000,000 | $5,500,000 | $16,500,000 | 11 | Jan 12, 2011 | sec.gov |
| Jun 10, 2010 | New notice | $15,000,000 | $5,500,000 | $9,500,000 | 16 | May 28, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Harry H. Penner, Jr. | Director | |
| C. Boyd H. Clarke | Director | |
| Jonathan S. Leff | Director | |
| Mark Leuchtenberger | Executive Officer, Director | |
| Cecilia S. Gonzalo | Director | |
| George M. Milne, Jr. | Director | |
| Robert Conerly | Executive Officer |
Other pharmaceuticals companies in Connecticut that filed recently
- Thetis Pharmaceuticals LLC $560,300 · Oct 13, 2026
- Inventure, LLC $82,345 · Sep 3, 2026
Every Form D from the week of Nov 26, 2012 · All recent filings in Connecticut · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Rib-X Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.